Position in LGVN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$54
-$27 QoQ
Shares Held
78
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 39 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aventura Private Wealth, LLC holds $606,898 across 23 Biotechnology names. LGVN ranks #23 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
267 | $166,485 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
10,000 | $87,550 | |
| 3 | OCS |
Oculis Holding AG
|
4,000 | $55,480 | |
| 4 | TECH |
BIO-TECHNE Corp
|
720 | $50,868 | |
| 5 | ARGX |
Argenx SE
|
50 | $46,388 | |
| 6 | NTLA |
Intellia Therapeutics, Inc.
|
1,990 | $33,670 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
62 | $33,290 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54 | $26,823 |
All Filings in LGVN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54 | 78 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $81 | 78 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $39 | 78 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $58 | 78 | Shares | Sole | 2026-01-07 | |
| 2025-06-30 | $101 | 78 | Shares | Sole | 2026-01-07 | |
| 2025-03-31 | $120 | 78 | Shares | Sole | 2026-01-07 | |
| 2024-12-31 | $134 | 78 | Shares | Sole | 2026-01-07 | |
| No filing history on record for this holder in this stock. | ||||||